Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Visitation 1	STARTED	Venlafaxine Group	22
Visitation 1	STARTED	Controlled Group	21
Visitation 1	COMPLETED	Venlafaxine Group	21
Visitation 1	COMPLETED	Controlled Group	20
Visitation 1	NOT COMPLETED	Venlafaxine Group	1
Visitation 1	NOT COMPLETED	Controlled Group	1
Visitation 2	STARTED	Venlafaxine Group	21
Visitation 2	STARTED	Controlled Group	20
Visitation 2	COMPLETED	Venlafaxine Group	19
Visitation 2	COMPLETED	Controlled Group	18
Visitation 2	NOT COMPLETED	Venlafaxine Group	2
Visitation 2	NOT COMPLETED	Controlled Group	2
Visitation 3	STARTED	Venlafaxine Group	19
Visitation 3	STARTED	Controlled Group	18
Visitation 3	COMPLETED	Venlafaxine Group	16
Visitation 3	COMPLETED	Controlled Group	16
Visitation 3	NOT COMPLETED	Venlafaxine Group	3
Visitation 3	NOT COMPLETED	Controlled Group	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03588572/flow